Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|May 5, 2021
Quantitative Proteome Data Analysis of Tandem Mass Tags Labeled SamplesOliver Pagel, Laxmikanth Kollipara, Albert SickmannMethods in Molecular Biology (Clifton, N.J.)|May 5, 2021
Tandem Mass Tags for Comparative and Discovery ProteomicsOliver Pagel, Laxmikanth Kollipara, Albert SickmannPlatelets|December 9, 2016
Taking the stock of granule cargo: Platelet releasate proteomicsOliver Pagel, Elena Walter, Kerstin Jurk, et al.Expert Review of Proteomics|May 9, 2015
Current strategies and findings in clinically relevant post-translational modification-specific proteomicsOliver Pagel, Stefan Loroch, Albert Sickmann, et al.Cells|February 23, 2020
The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human PlateletsElena J Kumm, Oliver Pagel, Stepan Gambaryan, et al.Nitric Oxide : Biology and Chemistry|March 19, 2018
Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human plateletsStephanie Makhoul, Elena Walter, Oliver Pagel, et al.Journal of Thrombosis and Haemostasis : JTH|July 22, 2020
The RhoA regulators Myo9b and GEF-H1 are targets of cyclic nucleotide-dependent kinases in plateletsShane Comer, Zoltan Nagy, Alfonso Bolado, et al.Scientific Reports|July 11, 2020
Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNASFrauke Swieringa, Fiorella A Solari, Oliver Pagel, et al.Science Translational Medicine|June 16, 2017
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Maximilian Riedel, Johannes Brägelmann, et al.Pageof 1